Yona Geffen Selected Research

Yona Geffen Research Topics

3	Schizophrenia (Dementia Praecox) 09/2012 - 01/2009
2	Cognitive Dysfunction 10/2019 - 09/2012
2	Catalepsy 01/2009 - 05/2008
1	Atrophy 10/2019
1	Alzheimer Disease (Alzheimer's Disease) 10/2019
1	Dementia (Dementias) 10/2019
1	Psychotic Disorders (Schizoaffective Disorder) 11/2010
1	Edema (Dropsy) 05/2009
1	Hyperalgesia 05/2009
1	Pain (Aches) 05/2009
1	Middle Cerebral Artery Infarction (Middle Cerebral Artery Syndrome) 02/2007
1	Stroke (Strokes) 02/2007

3	perphenazine GABA esterIBA 09/2012 - 01/2009
3	gamma-Aminobutyric Acid (GABA)IBA 05/2009 - 05/2008
2	Antipsychotic Agents (Antipsychotics)IBA 01/2009 - 05/2008
2	Perphenazine (Trilafon)FDA LinkGeneric 01/2009 - 05/2008
1	Apolipoproteins E (ApoE)IBA 10/2019
1	(N-propargyl-(3R) aminoindan-5-yl)-ethyl methyl carbamateIBA 10/2019
1	Risperidone (Risperdal Consta)FDA LinkGeneric 09/2012
1	Formaldehyde (Formol)FDA Link 05/2009
1	AmidesIBA 05/2009
1	Antidepressive Agents (Antidepressants)IBA 05/2009
1	CarrageenanIBA 05/2009
1	Fluoxetine (Prozac)FDA LinkGeneric 05/2009
1	Nortriptyline (Aventyl)FDA LinkGeneric 05/2009
1	CytokinesIBA 05/2009
1	Butyric Acid (Butanoic Acid)IBA 01/2009
1	Dopamine (Intropin)FDA LinkGeneric 01/2009
1	Amphetamine (Amfetamine)FDA LinkGeneric 01/2009
1	Prolactin Receptors (Prolactin Receptor)IBA 01/2009
1	ProlactinIBA 05/2008
1	Fluphenazine (Prolixin)FDA LinkGeneric 05/2008
1	EstersIBA 05/2008
1	Dextroamphetamine (Dexedrine)FDA LinkGeneric 05/2008
1	poly(tyrosyl-glutamic acid)IBA 02/2007

1	Therapeutics 02/2007